Preferential production of interferon-γ by CD4+ T cells expressing the homing receptor integrin α4/β7
Preferential production of interferon-γ by CD4+ T cells expressing the homing receptor integrin α4/β7
复制标题
DOI:
10.1046/j.0019-2805.2001.01234.x
复制
发表时间:
2001-06-01
期刊:
影响因子:
6.4
通讯作者:
Erle, DJ
中科院分区:
文献类型:
--
作者:
Abramson, O;Qiu, SQ;Erle, DJ
Recent studies indicate that T helper type 1 (Th1) and 2 (Th2) lymphocytes differ in their expression of molecules that control T-cell migration, including adhesion molecules and chemokine receptors. We investigated the relationship between cytokine production and expression of the homing receptor integrin alpha (4)/beta (7) on T cells. We began by analysing cytokine production by human CD4(+) CD45RA(-) memory/effector T cells following brief (4 hr) stimulation with phorbol 12-myristate 13-acetate (PMA) and ionomycin. alpha (4)/beta (high)(7) CD4(+) T cells were more likely to produce the Th1 cytokine interferon-gamma (IFN-gamma) than were alpha (4)/beta (-)(7) CD4(+) T cells in all six subjects studied. In contrast, production of the Th2 cytokine interleukin-4 (IL-4) was similar on alpha (4)/beta (high)(7) and alpha (4)/ beta (-)(7) CD4(+) T cells. In addition, we found that human CD4(+) CD45RA- T cells that adhered to the alpha (4)/beta (7) ligand mucosal addressin cell adhesion molecule-1 (MAdCAM-1) had a greater capacity to produce IFN-gamma than did non-adherent cells, suggesting that the association between alpha (4)/beta (7) expression and IFN-gamma production has functional significance. These results suggested that primary activation under Th1-promoting conditions might favour expression of alpha (4)/beta (7) we directly examined this possibility, and found that naive murine CD4+ T cells activated under Th1-promoting conditions expressed higher levels of alpha (4)/beta (7) compared to cells activated under Th2-promoting conditions. The association between alpha (4)/beta (7) expression and IFN-gamma production by CD4(+) T cells may help to determine the cytokine balance when MAdCAM-1 is expressed at sites of inflammation in the intestine or elsewhere.